Cited by 260Neuroinflammation and Neurodegeneration MechanismsTryptophan and brain disordersGenetics, Aging, and Longevity in Model Organisms

Immune aging, dysmetabolism, and inflammation in neurological diseases

Open access
Deleidi, Michela, Jäggle, Madeline, Rubino, Graziella·2015·Frontiers in Neuroscience

Abstract

As we age, the immune system undergoes a process of senescence accompanied by the increased production of proinflammatory cytokines, a chronic subclinical condition named as "inflammaging". Emerging evidence from human and experimental models suggest that immune senescence also affects the central nervous system and promotes neuronal dysfunction, especially within susceptible neuronal populations. In this review we discuss the potential role of immune aging, inflammation and metabolic derangement in neurological diseases. The discovery of novel therapeutic strategies targeting age-linked inflammation may promote healthy brain aging and the treatment of neurodegenerative as well as neuropsychiatric disorders.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fnins.2015.00172

Cites

247 of 247 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Peripheral inflammaging leads to low-level production of inflammatory mediators in circulation (IL-6, TNF-α, CRP), which contribute to inflammatory environment in CNS.

    “At the systemic level, peripheral inflammaging leads to low-level production of inflammatory mediators in the circulation, including IL-6, TNF-α, and C-reactive protein (CRP), which also contribute to the inflammatory environment in the CNS.36,49,116”

    From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [116]

    The ‘Immunosenescence and inflammaging’ section describes low-grade inflammation with increased IL-6, TNF-α and acute-phase proteins; ‘Brain cell senescence and neuro-inflammaging’ says peripheral inflammaging can drive low-grade brain inflammation. The paper names CRP in its discussion of obesity-associated inflammation, but does not specifically identify it as a product of peripheral inflammaging or show that CRP itself contributes to CNS inflammation. The indexed passages provide section labels but no page numbers. (LLM, conf=0.84)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Deleidi, M., Jäggle, M., & Rubino, G.
Affiliations
  • German Center for Neurodegenerative Diseases (DE)
  • University of Tübingen (DE)
Corresponding author
Deleidi, Michela
Venue
Frontiers in Neuroscience
Published
2015-06-03
Volume
9
Pages
172-172
ISSN
1662-453X (ISSN-L)
OpenAlex
W1486303545
Cited by
260
References
247
Citations by year
2026: 15 · 2025: 12 · 2024: 18 · 2023: 27 · 2022: 37 · 2021: 23 · 2020: 26 · 2019: 26 · 2018: 28 · 2017: 26 · 2016: 17 · 2015: 5
FWCI
2.02
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Frontiers in Neuroscience (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • DZNE Pub (submittedVersion, other-oa)
Funders
  • European Commission (304108)
  • Fritz Thyssen Stiftung
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
Keywords
immunosenescence, inflammaging, neuroinflammation, neurodegenerative diseases, neuropsychiatric disorders, inflammatory cytokines, brain aging, neuronal dysfunction, anti-inflammatory therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review